SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biochem Pharma (BCHE)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
783 13 0 BCHE
Emcee:  Constant Reader Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
208 Once again, Viracept is a protease inhibitor while 3-TC is a reverse transcriptbiodoc-1/8/1998
207 Isn't AGPH's Viracept a competitor to 3TC?Steve Childs-1/8/1998
206 Typically, a 3-drug AIDS combo includes AZT & 3TC, along with a protease inTodd D. Wiener-1/6/1998
205 Correct me if Im wrong but all combinations must have 3TC to be effective.johne-1/6/1998
204 nelfinavir and 3-TC are NOTcompetitor drugs. Single agent therapy is no longerbiodoc-1/6/1998
203 I sold BCHE at 31 1/2. Bought in again at 20 3/4. So far, so good. I noticed Steve Childs-1/5/1998
202 Anybody have any idea when we can excpect BCHE to announce the numbers for the Del Holmes-1/1/1998
201 MSG? Sure it does. BCHE would be in great shape if Lamivudine could cure the ATodd D. Wiener-12/26/1997
200 Just in, MSG causes Hepatitus B! Will try to post a link ASAP.David S.-12/26/1997
199 Ted, Thanks for the info. I also agree that a lot of the weakness is due to Wade Sickler-12/26/1997
198 Wade, I saw a blip on the news about the Canadian dollar being weak. I then cheTed Downs-12/25/1997
197 [problems of the Canadian dollar?] Ted, I have not been following this cloWade Sickler-12/25/1997
196 Randy, Anyone know if the weakness in bche is associated with the problems of tTed Downs-12/24/1997
195 BCHE concludes agreements with Scriptgen plus 20% eouity investment. PR newsjohne-12/21/1997
194 Todd Stock strong. Overlooked too. Owned for years. Jerryjbershad-12/12/1997
193 FORGET OXFORD HEALTHCARE, TRY BIOCHEM PTodd D. Wiener-12/8/1997
192 Here are some more informative links (CBC & Toronto Star): newsworld.cbc.cStewart Whitman-11/26/1997
191 Thank you StewHarold-11/26/1997
190 At little more here... biz.yahoo.com StewStewart Whitman-11/25/1997
189 Todd do you have any idea what happened this morning? This news release is puzzHarold-11/25/1997
188 More news: biz.yahoo.comHarold-11/17/1997
187 I do expect GLX to buy BCHE at some point. No one knows when it might happen. ITodd D. Wiener-11/16/1997
186 Todd, I agree with everything you said. Actually, I have been wondering if GlaxSteve Goldstein-11/16/1997
185 Steve- BCHE is very cheap compared with the other profitable biotechs. I thinkTodd D. Wiener-11/11/1997
184 Todd, I still believe BCHE will do well although I'm disappointed in recentSteve Goldstein-11/11/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News